Pulse Biosciences, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Pulse Biosciences, Inc. on January 29, 2018, covering events occurring between January 23, 2018, and January 26, 2018. The company is incorporated in Nevada and is designated as an emerging growth company.
Key Financial Metrics
This filing does not report revenue, profit, cash flow, margins, debt, or liquidity metrics. The document focuses exclusively on corporate governance and executive compensation adjustments.
Material Changes
- Executive Compensation Increases: The Compensation Committee and Board approved base salary increases effective January 1, 2018, for two named executive officers:
- Brian B. Dow: Base salary increased from $260,000 to $336,000.
- Darrin R. Uecker: Base salary increased from $330,000 to $461,000.
- Performance Bonus Adjustments: Target bonus percentages for 2018 were increased for both executives:
- Brian B. Dow: Increased from 25% to 30% of base salary.
- Darrin R. Uecker: Increased from 35% to 45% of base salary.
- Indemnification Agreement: On January 26, 2018, the Board approved a new form of Indemnification Agreement for Board members, Section 16 executive officers, and other appointed officers. This agreement supersedes previous forms and obligates the company to indemnify and advance expenses for legal matters related to their service, subject to legal limits and specific procedures.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, or management commentary regarding future business performance. The primary risk disclosed relates to the company's obligation to indemnify directors and officers, which could result in future cash outflows if legal proceedings arise, though the filing notes these obligations are subject to exclusions and repayment conditions if indemnification is not ultimately warranted.
Investor Verification Checklist
- Verify the exact effective date of the salary and bonus changes (stated as January 1, 2018) against payroll records.
- Review the full text of the New Indemnification Agreement (Exhibit 10.1) to understand specific exclusions and repayment procedures.
- Confirm the total potential annual compensation impact for Mr. Dow and Mr. Uecker based on the new base salaries and maximum bonus percentages.
- Check subsequent filings for any changes to the Board composition or executive roles that might affect these agreements.